H Nomura

Summary

Country: Japan

Publications

  1. ncbi request reprint Interferon-beta plus ribavirin therapy can be safely and effectively administered to elderly patients with chronic hepatitis C
    Hideyuki Nomura
    The Center for Liver Disease, Shin Kokura Hospital, Kitakyushu, Japan Electronic address
    J Infect Chemother 20:489-92. 2014
  2. doi request reprint Increase in platelet count based on inosine triphosphatase genotype during interferon beta plus ribavirin combination therapy
    Hideyuki Nomura
    The Center for Liver Disease, Shin Kokura Hospital, Kitakyushu, Japan
    J Gastroenterol Hepatol 27:1461-6. 2012
  3. ncbi request reprint A short-term eradication therapy for Helicobacter pylori acute gastritis
    H Nomura
    Department of Internal Medicine, Shin Kokura Hospital, 1 3 1, Kanada, Kokurakita ku, Kitakyushu 803 8505, Japan
    J Gastroenterol Hepatol 15:1377-81. 2000
  4. ncbi request reprint Short-term interferon-alfa therapy for acute hepatitis C: a randomized controlled trial
    Hideyuki Nomura
    Department of Internal Medicine, Shin Kokura Hospital, Fukuoka, Japan
    Hepatology 39:1213-9. 2004
  5. ncbi request reprint Factors contributing to ribavirin-induced anemia
    Hideyuki Nomura
    Department of Internal Medicine, Shin Kokura Hospital, Kitakyushu, Fukuoka, Japan
    J Gastroenterol Hepatol 19:1312-7. 2004
  6. doi request reprint Impact of early viral kinetics on pegylated interferon alpha 2b plus ribavirin therapy in Japanese patients with genotype 2 chronic hepatitis C
    H Nomura
    The Center for Liver Diseases, Shin Kokura Hospital, Kitakyushu, Fukuoka, Japan
    J Viral Hepat 16:346-51. 2009
  7. doi request reprint Effective prediction of outcome of combination therapy with pegylated interferon alpha 2b plus ribavirin in Japanese patients with genotype-1 chronic hepatitis C using early viral kinetics and new indices
    Hideyuki Nomura
    The Center for Liver Diseases, Shin Kokura Hospital, 1 3 1 Kanada, Kokurakitaku, Kitakyushu, Fukuoka, 803 8505, Japan
    J Gastroenterol 44:338-45. 2009

Detail Information

Publications7

  1. ncbi request reprint Interferon-beta plus ribavirin therapy can be safely and effectively administered to elderly patients with chronic hepatitis C
    Hideyuki Nomura
    The Center for Liver Disease, Shin Kokura Hospital, Kitakyushu, Japan Electronic address
    J Infect Chemother 20:489-92. 2014
    ..This study aims to evaluate the efficacy and safety of interferon-beta plus ribavirin therapy in older Japanese patients...
  2. doi request reprint Increase in platelet count based on inosine triphosphatase genotype during interferon beta plus ribavirin combination therapy
    Hideyuki Nomura
    The Center for Liver Disease, Shin Kokura Hospital, Kitakyushu, Japan
    J Gastroenterol Hepatol 27:1461-6. 2012
    ..We investigated decreases in platelet counts according to ITPA genotype during natural IFN-β/ribavirin therapy to determine if patients with low platelet counts were eligible for this combination therapy...
  3. ncbi request reprint A short-term eradication therapy for Helicobacter pylori acute gastritis
    H Nomura
    Department of Internal Medicine, Shin Kokura Hospital, 1 3 1, Kanada, Kokurakita ku, Kitakyushu 803 8505, Japan
    J Gastroenterol Hepatol 15:1377-81. 2000
    ..pylori), may resolve spontaneously, but the infection sometimes becomes chronic. We examined the efficacy of a short-term H. pylori eradication therapy on acute gastritis...
  4. ncbi request reprint Short-term interferon-alfa therapy for acute hepatitis C: a randomized controlled trial
    Hideyuki Nomura
    Department of Internal Medicine, Shin Kokura Hospital, Fukuoka, Japan
    Hepatology 39:1213-9. 2004
    ..021 and P =.006, respectively). In conclusion, short-term (4 weeks) IFN treatment of patients with acute hepatitis C may be associated with satisfactory results, if initiated at an early stage of the disease...
  5. ncbi request reprint Factors contributing to ribavirin-induced anemia
    Hideyuki Nomura
    Department of Internal Medicine, Shin Kokura Hospital, Kitakyushu, Fukuoka, Japan
    J Gastroenterol Hepatol 19:1312-7. 2004
    ..Interferon and ribavirin combination therapy for chronic hepatitis C produces hemolytic anemia. This study was conducted to identify the factors contributing to ribavirin-induced anemia...
  6. doi request reprint Impact of early viral kinetics on pegylated interferon alpha 2b plus ribavirin therapy in Japanese patients with genotype 2 chronic hepatitis C
    H Nomura
    The Center for Liver Diseases, Shin Kokura Hospital, Kitakyushu, Fukuoka, Japan
    J Viral Hepat 16:346-51. 2009
    ..The RI (<or=1.0) was the only significant independent factor for SVR by multiple logistic regression analysis and is the first predictive factor in 24-week peginterferon plus ribavirin therapy for patients infected with genotype 2...
  7. doi request reprint Effective prediction of outcome of combination therapy with pegylated interferon alpha 2b plus ribavirin in Japanese patients with genotype-1 chronic hepatitis C using early viral kinetics and new indices
    Hideyuki Nomura
    The Center for Liver Diseases, Shin Kokura Hospital, 1 3 1 Kanada, Kokurakitaku, Kitakyushu, Fukuoka, 803 8505, Japan
    J Gastroenterol 44:338-45. 2009
    ..We investigated whether SVR and transient response (TR) can be differentiated during treatment using new indices calculated from early viral kinetics and the timing of when hepatitis C virus (HCV)-RNA becomes undetectable...